Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
<p>Abstract</p> <p>Background</p> <p>Recent data provide significant evidence to support the hypothesis that there are sub-populations of cells within solid tumors that have an increased tumor initiating potential relative to the total tumor population. CD133, a cell su...
Main Authors: | Borger Darrell R, Belden Sarah E, Sergent Petra A, Therrien Vanessa A, Curley Michael D, Zhang Ling, Friel Anne M, Mohapatra Gayatry, Zukerberg Lawrence R, Foster Rosemary, Rueda Bo R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-12-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.rbej.com/content/8/1/147 |
Similar Items
-
Prognostic impact of CD133 expression in Endometrial Cancer Patients
by: G. Mancebo, et al.
Published: (2017-08-01) -
Generation of Anti-CD133 Human Synthetic Antibodies as Tools for Exploring CD133 Function
by: Williams, Rashida
Published: (2013) -
Generation of Anti-CD133 Human Synthetic Antibodies as Tools for Exploring CD133 Function
by: Williams, Rashida
Published: (2013) -
CD133 Expression in the Nucleus Is Associated with Endometrial Carcinoma Staging and Tumor Angioinvasion
by: Milosz Pietrus, et al.
Published: (2021-05-01) -
CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
by: Jiri Sana, et al.
Published: (2011-01-01)